HIV pills

NICE approves first long-acting injectable HIV-1 treatment

NICE has today published draft guidance recommending the first long-acting injectable treatment for HIV-1 infection in adults.

Today’s draft guidance is the first time NICE has made recommendations about the use of an HIV treatment since these came under NICE’s remit in 2019.

It is estimated that around 13,000 people will now be eligible for treatment with cabotegravir with rilpivirine in England.

Current treatment for HIV‑1 is lifelong antiretroviral tablets taken each day, with the aim being to keep the number of virus particles in the blood (the viral load) so low that it cannot be detected or transmitted between people.

Cabotegravir (also called Vocabria and made by Viiv Healthcare) with rilpivirine (also called Rekambys and made by Janssen), is recommended as an option for adults with HIV-1 infection for a number of reasons.

This includes when antiretroviral medicines they are already taking to treat HIV-1 have kept the virus at a low level and where there is no evidence to suspect viral resistance, as well as no previous failure of other anti-HIV-1 medicines called nonnucleoside reverse transcriptase inhibitors (NNRTIs) and integrase inhibitors (INIs).

Clinical trial results show that cabotegravir with rilpivirine is as effective as oral antiretrovirals at keeping the viral load low.

Both cabotegravir and rilpivirine are administered as two separate injections every two months, after an initial oral (tablet) lead-in period.

Commenting, Deputy Chief Executive and Director of the Centre for Health Technology Assessment at NICE, Meindert Boysen said:

“Despite scientific advances, HIV is still incurable, but the virus can be controlled by modern treatment.

“However, for some people, having to take daily multi-tablet regimens can be difficult because of drug related side effects, toxicity and other psychosocial issues, such as stigma or changes in lifestyle.

“The committee heard that stigma remains an issue for people living with HIV and can have a negative impact on people’s health and relationships.

“We’re pleased therefore to be able to recommend cabotegravir with rilpivirine as a valuable treatment option for people who already have good levels of adherence to daily tablets, but who might prefer an injectable regimen with less frequent dosing.”

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities

Videos...

View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all